NeurologyLive® Friday 5 — July 1, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 1, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Pioneering Care for Autoimmune Disorders Through Research and Results: The Mayo Clinic Way

In the latest iteration of our Gold Standard Centers, through dedicated research into biomarker discovery and patient care, the neuroimmunology laboratory at Mayo Clinic has paved a new way of life for those with autoimmune disorders.

Pioneering Care for Autoimmune Disorders Through Research and Results: The Mayo Clinic Way

2: AHS 2022: Top Interviews and Key Takeaways

The NeurologyLive® team assembled some of the best discussions with leaders in headache and migraine medicine following the 2022 American Headache Society (AHS) Annual Scientific Meeting.

AHS 2022: Top Interviews and Key Takeaways

3: NeuroVoices: Heidi Schambra, MD, on Expanding Capabilities of Stroke Rehabilitation With the PrimSeq Digital Tool

The associate professor in the Department of Rehabilitation Medicine at NYU Langone discussed a recent study on a new tool aimed at quantifying movements during stroke rehabilitation and provided insight on advantages it might bring to the field, the overall quantitative approach, and the main take-home points from the study.

NeuroVoices: Heidi Schambra, MD, on Expanding Capabilities of Stroke Rehabilitation With the PrimSeq Digital Tool

4: News Network: Brain and Cognitive Changes in Multiple Sclerosis

In this European Academy of Neurology Annual Congress-themed NeurologyLive® News Network, John DeLuca, PhD, provides an overview of changes in cognition and brain volume loss in patients with multiple sclerosis.

News Network: Brain and Cognitive Changes in Multiple Sclerosis

5: Involving Patients in the Conversation About Parkinson Disease Treatment Approaches: Jill Farmer, DO, MPH

As the individualized needs of patients are further prioritized in Parkinson disease care, the director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute shared her perspective on shared decision-making.

Involving Patients in the Conversation About Parkinson Disease Treatment Approaches: Jill Farmer, DO, MPH

—————————————————

Related Videos
 Jocelyn Y. Cheng, MD
Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS
David Z. Rose, MD
Shadi Yaghi, MD, associate professor of neurology at Brown University
© 2024 MJH Life Sciences

All rights reserved.